MYRIAD GENETICS INC
MYGN·62855J104·US·Common Stock·Healthcare - Diagnostics & Research-13D/G
MYGN (MYRIAD GENETICS INC) is held by 119 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($62.2M), MILLENNIUM MANAGEMENT LLC ($37.8M), STATE STREET CORP ($28.5M). Net institutional sentiment: Mixed.
119
Holders
(10 Elite)
$443.9M
Total Value
53% (135)
Consensus
72 buying - 63 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Sep 22, 2026 · Activists Sep 4, 2026 · Congress none
InsiderWRWheeler Benjamin RichardTax 3K shSep 21, 2026
InsiderSVSikri VishalVest 258K shSep 16, 2026
ActivistBPBlackRock Portfolio Management LLC10.4%Sep 4, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 140
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer